Functional antitumor vaccine constructs are the basis for active tumor immunotherapy, which is useful in the treatment of many types of cancers. MUC1 is one key protein for targeting and designing new strategies for multi-component vaccines. Two self-adjuvant tetravalent vaccine candidates were prepared by clustering four or eight PDTRP MUC1 core epitope sequences on calixarene scaffolds. In this work, the different activities of two molecules with calix[4]arene and calix[8]arene skeleton are rationalized. Quantum-Mechanics, Docking and Molecular Dynamics structural optimization were firstly carried out followed by Metadynamics to calculate the energy profiles. Further insights were obtained by molecular fields' complementarity studies. The molecular modelling results are in strong agreement with the experimental in vivo immunogenicity data. In conclusion, the overall data shows that in the designing of anticancer vaccines, the scaffold flexibility has a pivotal role in obtaining a suitable electrostatic, hydrophobic and steric complementarity with the biological target.
Quantum chemical and molecular dynamics studies of MUC-1 calix[4,8]arene scaffold based anti-cancer vaccine candidates
	
	
	
		
		
		
		
		
	
	
	
	
	
	
	
	
		
		
		
		
		
			
			
			
		
		
		
		
			
			
				
				
					
					
					
					
						
							
						
						
					
				
				
				
				
				
				
				
				
				
				
				
			
			
		
			
			
				
				
					
					
					
					
						
							
						
						
					
				
				
				
				
				
				
				
				
				
				
				
			
			
		
			
			
				
				
					
					
					
					
						
							
						
						
					
				
				
				
				
				
				
				
				
				
				
				
			
			
		
			
			
				
				
					
					
					
					
						
							
						
						
					
				
				
				
				
				
				
				
				
				
				
				
			
			
		
			
			
				
				
					
					
					
					
						
						
							
							
						
					
				
				
				
				
				
				
				
				
				
				
				
			
			
		
			
			
				
				
					
					
					
					
						
							
						
						
					
				
				
				
				
				
				
				
				
				
				
				
			
			
		
			
			
				
				
					
					
					
					
						
						
							
							
						
					
				
				
				
				
				
				
				
				
				
				
				
			
			
		
			
			
				
				
					
					
					
					
						
							
						
						
					
				
				
				
				
				
				
				
				
				
				
				
			
			
		
		
		
		
	
Spadaro, Angelo
						
						
							Primo
;Basile, Livia;Pappalardo, Matteo
;Bonaccorso, Carmela;Ronsisvalle, Simone;Guccione, Salvatore
	
		
		
	
			2020-01-01
Abstract
Functional antitumor vaccine constructs are the basis for active tumor immunotherapy, which is useful in the treatment of many types of cancers. MUC1 is one key protein for targeting and designing new strategies for multi-component vaccines. Two self-adjuvant tetravalent vaccine candidates were prepared by clustering four or eight PDTRP MUC1 core epitope sequences on calixarene scaffolds. In this work, the different activities of two molecules with calix[4]arene and calix[8]arene skeleton are rationalized. Quantum-Mechanics, Docking and Molecular Dynamics structural optimization were firstly carried out followed by Metadynamics to calculate the energy profiles. Further insights were obtained by molecular fields' complementarity studies. The molecular modelling results are in strong agreement with the experimental in vivo immunogenicity data. In conclusion, the overall data shows that in the designing of anticancer vaccines, the scaffold flexibility has a pivotal role in obtaining a suitable electrostatic, hydrophobic and steric complementarity with the biological target.| File | Dimensione | Formato | |
|---|---|---|---|
| Spadaro A., Livia Basile, Matteo Pappalardo,* Carmela Bonaccorso, Ronsisvalle s. 2020.pdf solo gestori archivio 
											Tipologia:
											Versione Editoriale (PDF)
										 
										Dimensione
										7.3 MB
									 
										Formato
										Adobe PDF
									 | 7.3 MB | Adobe PDF | Visualizza/Apri | 
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.


